4.7 Article

Population based study: atopy and autoimmune diseases are associated with functional dyspepsia and irritable bowel syndrome, independent of psychological distress

Journal

ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Volume 49, Issue 5, Pages 546-555

Publisher

WILEY
DOI: 10.1111/apt.15120

Keywords

-

Ask authors/readers for more resources

Background The pathogenesis of functional GI disorders (FGIDs) is uncertain. However, underlying immune activation and psychological distress has been documented in irritable bowel syndrome (IBS) and functional dyspepsia (FD). Epidemiological data from the UK suggest that FGIDs are linked to atopy and certain autoimmune diseases but this has not been confirmed. Aim To test if allergic or autoimmune diseases are independently associated with FGIDs, irrespective of psychological distress in a large population based study. Methods A total of 3542 people (mean age 57.9 years and 52.7% females) randomly selected from the Australian population, returned a mail survey (response rate = 43%). The survey asked about a physician diagnosis of autoimmune disease (scleroderma, psoriasis, rheumatoid arthritis and diabetes mellitus) or allergic conditions (asthma, food, pollen and/or animal allergy). The questionnaire assessed psychological distress and Rome III criteria for FD and IBS. Results Asthma, food, pollen and animal allergies, psoriasis and rheumatoid arthritis were univariately significantly associated with IBS and FD. Food allergy (OR = 1.66; 95% CI = 1.15-2.40, P = 0.007), psoriasis (OR = 1.81; 95% CI = 1.19-2.74, P = 0.006) and rheumatoid arthritis (OR = 1.68; 95% CI = 1.15-2.4, P = 0.007) were independent risk factors for IBS, controlling for age, gender and psychological distress. In FD, asthma (OR = 1.32; 95% CI = 1.04-1.68, P = 0.025) and food allergy (OR = 1.78; 95% CI = 1.28-2.49, P = 0.001) were independent predictors, controlling for age, sex and psychological distress. Conclusions There is evidence that both atopic and autoimmune diseases are risk factors for FGIDs, independent of psychological distress, differing in IBS and FD. This provides evidence that different peripheral pathways may be involved in the pathogenesis of certain FGIDs.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Gastroenterology & Hepatology

Alterations to the duodenal microbiota are linked to gastric emptying and symptoms in functional dyspepsia

Erin R. Shanahan, Seungha Kang, Heidi Staudacher, Ayesha Shah, Anh Do, Grace Burns, Veronique S. Chachay, Natasha A. Koloski, Simon Keely, Marjorie M. Walker, Nicholas J. Talley, Mark Morrison, Gerald J. Holtmann

Summary: This study indicates a link between duodenal microbiota, gastric emptying, and FD symptoms, and this link is largely independent of long-term dietary intake.
Article Gastroenterology & Hepatology

Diabetes mellitus is an independent risk factor for a greater frequency of early satiation and diarrhea at one and three years: Two prospective longitudinal population-based studies

Natasha A. Koloski, Michael Jones, Marjorie M. Walker, Michael Horowitz, Gerald Holtmann, Nicholas J. Talley

Summary: Diabetes is an independent risk factor for an increased frequency of gastrointestinal symptoms, adjusting for lifestyle and psychological factors.

NEUROGASTROENTEROLOGY AND MOTILITY (2023)

Review Gastroenterology & Hepatology

Placebo response in pharmacological trials in patients with functional dyspepsia-A systematic review and meta-analysis

Michelle Bosman, Fabienne Smeets, Sigrid Elsenbruch, Jan Tack, Magnus Simren, Nicholas Talley, Bjorn Winkens, Ad Masclee, Daniel Keszthelyi

Summary: This study conducted a systematic review and meta-analysis to investigate the placebo response in pharmacological trials for functional dyspepsia (FD). The study found that the pooled placebo response rate ranged from 35.5% to 39.6% depending on the responder definition used. Lower baseline symptom scores were significantly associated with higher placebo response rates. The study suggests considering entry criteria based on symptom severity and separate reporting of core FD symptoms in future trials.

NEUROGASTROENTEROLOGY AND MOTILITY (2023)

Article Gastroenterology & Hepatology

Economic living standard and abdominal pain mediate the association between functional gastrointestinal disorders and depression or anxiety

M. H. Simon, P. E. Heenan, C. Frampton, S. Bayer, J. Keenan, de N. K. Boer, N. C. Roy, N. J. Talley, R. B. Gearry

Summary: This study examines the association between functional gastrointestinal disorders (FGIDs) and depression and anxiety, and identifies the covariates influencing this association. The study finds that economic standard of living, pain, and IBS phenotype are significant independent factors associated with depression and anxiety in FGID cases.

NEUROGASTROENTEROLOGY AND MOTILITY (2023)

Review Gastroenterology & Hepatology

Placebo effects in functional dyspepsia: Causes and implications for clinical trials

Michael P. Jones, Gerald Holtmann

Summary: Placebo responses provide insights into mechanisms beyond the intervention and affect the potential efficacy of new interventions in clinical trials. This mini-review discusses the systematic review and meta-analysis conducted by Bosman and colleagues on placebo response in functional dyspepsia clinical trials. It also explores potential mechanisms of placebo response in the context of brain-gut interaction disorders and extra-gastrointestinal disorders.

NEUROGASTROENTEROLOGY AND MOTILITY (2023)

Article Gastroenterology & Hepatology

Experiencing multiple concurrent functional gastrointestinal disorders is associated with greater symptom severity and worse quality of life in chronic constipation and defecation disorders

Adam I. I. Kaplan, Yoav Mazor, Gillian M. M. Prott, Carol Sequeira, Michael P. Jones, Allison Malcolm

Summary: Recent community-based studies have found that having multiple concurrent functional gastrointestinal disorders (FGIDs) is associated with increased somatization, worse quality of life (QoL), and greater healthcare utilization. However, the presence of multiple overlapping FGIDs specifically in chronic constipation and functional defecation disorders (FDD) has not been studied. This study investigated the prevalence and impact of additional nonconstipation FGIDs on constipation severity, anorectal physiology, anxiety and depression, and QoL in patients with chronic constipation and FDD.

NEUROGASTROENTEROLOGY AND MOTILITY (2023)

Article Gastroenterology & Hepatology

Do prokinetic agents provide symptom relief through acceleration of gastric emptying? An update and revision of the existing evidence

Nick Goelen, Mike Jones, I-Hsuan Huang, Florenca Carbone, Pieter Janssen, Jan Tack

Summary: Gastroparesis and functional dyspepsia are disorders characterized by upper gastrointestinal symptoms and multifaceted etiologies. The association between symptom improvement and acceleration of gastric emptying (GE) by prokinetic agents is not clear. This meta-analysis aimed to provide a transparent update on the association between symptom improvement and GE acceleration in patients with gastroparesis.

UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2023)

Letter Gastroenterology & Hepatology

Letter: childhood recurrent abdominal pain is associated with increased duodenal eosinophilia independent of Helicobacter pylori infection

Lucas Wauters, Paul R. Harris, Marjorie M. Walker, Carolina A. Serrano, Andrea Villagran, Gurpreet S. Rakhra, Jean E. Crabtree, Nicholas J. Talley

Summary: This article is connected to the paper by Broeders et al. To access this article, visit the provided link.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2023)

Review Allergy

Understanding food allergy through neuroimmune interactions in the gastrointestinal tract

Grace L. Burns, Simon Keely

Summary: This article evaluates the contribution of local enteric neuroimmune interactions to the immune response in food allergies, and discusses considerations for targeting neuroimmune pathways in the treatment of food allergies.

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2023)

Review Medicine, General & Internal

Weight loss with subcutaneous semaglutide versus other glucagon-like peptide 1 receptor agonists in type 2 diabetes: a systematic review

Brandon Stretton, Joshua Kovoor, Stephen Bacchi, Shantel Chang, Benjamin Ngoi, Tess Murray, Thomas C. Bristow, Jonathan Heng, Aashray Gupta, Christopher Ovenden, Guy Maddern, Campbell H. Thompson, Leonie Heilbronn, Mark Boyd, Christopher Rayner, Nicholas J. Talley, Michael Horowtiz

Summary: This review summarizes the direct comparisons between subcutaneous semaglutide and other GLP-1 RAs in individuals with type 2 diabetes, focusing on their efficacy for inducing weight loss and improving metabolic health markers. Five studies which fulfilled the inclusion criteria were identified. Randomized trials support the superior efficacy of semaglutide over other GLP-1 RAs in terms of weight loss, but tirzepatide is more effective than semaglutide.

INTERNAL MEDICINE JOURNAL (2023)

Article Veterinary Sciences

Comparison of agarose gel and capillary zone electrophoresis methods with preliminary reference interval generation using capillary zone electrophoresis in bald eagles (Haliaeetus leucocephalus)

Leandro Abreu da Fonseca, Fabiano Montiani-Ferreira, Jeny Soto, Michael P. Jones, Nancy Zagaya, Carolyn Cray

Summary: This study compared agarose gel electrophoresis (AGE) and capillary zone electrophoresis (CZE) methods and determined reference intervals for CZE using plasma from bald eagles. The results showed that these two methods are not equivalent, and CZE demonstrated better resolution and reproducibility for protein fraction quantitation.

VETERINARY CLINICAL PATHOLOGY (2023)

Article Gastroenterology & Hepatology

Increased mucosal eosinophils in colonic diverticulosis and diverticular disease

Raquel Cameron, Marjorie M. Walker, Michael Jones, Guy D. Eslick, Simon Keely, Peter Pockney, Carolina C. Cosentino, Nicholas J. Talley

Summary: This study examined the changes of eosinophils and other immune cells in the mucosa of colonic diverticula through quantitative histology. The results showed a significant increase in eosinophil counts at the base and neck of the diverticula. These findings provide new clues for understanding the role of eosinophils and chronic inflammation in the pathophysiology of colonic diverticulosis.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2023)

Article Psychiatry

Moment-to-moment relationships between pain, fatigue, and distress as a function of GI symptoms in fibromyalgia

Anastasia Ejova, Michael P. Jones, Alissa P. Beath, Sarah L. Mckerchar, Akiko Okifuji

Summary: There is evidence that people with both fibromyalgia and functional gastrointestinal disorders experience more severe psychological symptoms. Using Ecological Momentary Assessment (EMA), this study found that for individuals with fibromyalgia, accompanying GI symptoms lead to stronger bidirectional relationships between distress and bodily pain or fatigue.

JOURNAL OF PSYCHOSOMATIC RESEARCH (2023)

Article Gastroenterology & Hepatology

Development and Validation of a Patient-Reported Experience Measure for Gastrointestinal Endoscopy The Comprehensive Endoscopy Satisfaction Tool (CEST)

Marguerite J. Kutyla, Jessica J. McMaster, Adam Haig, Natasha Koloski, Luke Hourigan, Vera Meeusen, Ayesha Shah, Nicholas J. Talley, Michael P. Jones, Gerald J. Holtmann

Summary: This study aimed to develop and validate a patient-reported experience measure for GI endoscopy. The Comprehensive Endoscopy Satisfaction Tool captures relevant domains that influence the patient's experience and identifies factors that shape satisfaction. The tool was tested in a large number of patients and found to be valid and responsive.

JOURNAL OF CLINICAL GASTROENTEROLOGY (2023)

No Data Available